Valley Brook Capital Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
3,145
-230
| -7% | -$93.3K | 0.95% | 28 |
|
|
2025
Q1 | $1.68M | Sell |
3,375
-1,035
| -23% | -$515K | 1.32% | 22 |
|
|
2024
Q4 | $2.29M | Sell |
4,410
-475
| -10% | -$247K | 1.71% | 14 |
|
|
2024
Q3 | $3.02M | Buy |
4,885
+25
| +0.5% | +$15.5K | 2.17% | 11 |
|
|
2024
Q2 | $2.69M | Buy |
4,860
+100
| +2% | +$55.3K | 2.1% | 10 |
|
|
2024
Q1 | $2.77M | Buy |
4,760
+100
| +2% | +$58.1K | 2.21% | 10 |
|
|
2023
Q4 | $2.47M | Buy |
4,660
+150
| +3% | +$79.6K | 2.15% | 8 |
|
|
2023
Q3 | $2.28M | Buy |
4,510
+230
| +5% | +$116K | 2.26% | 8 |
|
|
2023
Q2 | $2.23M | Sell |
4,280
-60
| -1% | -$31.3K | 2.06% | 9 |
|
|
2023
Q1 | $2.5M | Buy |
4,340
+60
| +1% | +$34.6K | 2.31% | 9 |
|
|
2022
Q4 | $2.36M | Buy |
4,280
+35
| +0.8% | +$19.3K | 2.26% | 10 |
|
|
2022
Q3 | $2.15M | Buy |
4,245
+10
| +0.2% | +$5.07K | 2.35% | 9 |
|
|
2022
Q2 | $2.3M | Sell |
4,235
-10
| -0.2% | -$5.43K | 2.37% | 9 |
|
|
2022
Q1 | $2.51M | Buy |
4,245
+210
| +5% | +$124K | 2.16% | 11 |
|
|
2021
Q4 | $2.69M | Buy |
4,035
+20
| +0.5% | +$13.3K | 2.32% | 9 |
|
|
2021
Q3 | $2.29M | Sell |
4,015
-30
| -0.7% | -$17.1K | 2.27% | 11 |
|
|
2021
Q2 | $2.04M | Buy |
4,045
+330
| +9% | +$166K | 1.94% | 13 |
|
|
2021
Q1 | $1.7M | Buy |
3,715
+120
| +3% | +$54.8K | 1.53% | 14 |
|
|
2020
Q4 | $1.67M | Buy |
+3,595
| New | +$1.67M | 1.66% | 14 |
|